Could Toxic Gut Bacteria Be the Answer to New MS Therapies?
Image by Nicoletta Barolini – check out her images on: https://www.nicolettabarolini.com/ Advanced Science Research Center (City University of NY) made an amazing discovery that may…
MS Treatment
Wyoming Jeepers
Melissa Cook, September 2020 – Shoshone National Park, Wyoming
Lemtrada Receives FDA Approval for New MS Treatment
Genzyme’s Lemtrada is the latest medication to be approved by the FDA as a treatment plan for multiple sclerosis under a restricted distribution program. The…
MSsymptoms.me: Double Donations for National MS Society
The National MS Society is excited to share that David and Eula Wintermann Foundation are matching donations until November 17th for a total of $100,000….
MSsymptoms.me: Alfacalcidol for Fatigue?
Alfacalcidol is man-made vitamin D used to treat deficiency. The researchers in Israel believed Alfacalcidol could help with MS fatigue and they were correct. The…
MS symptoms: Immunotherapy Methods in MS Treatment
Imagine being able to stop the immune system from attacking the myelin in the brain! A new study exposed mice to “fragments of the components…
MS symptoms: FDA Approved Plegridy as MS Treatment
Before you get too excited about the new MS treatment, Pledgridy, let me first explain that it really is not new but rather New and Improved. Biogen Idec, the…
MS symptoms: Worms Could Mean a New MS Treatment Pill in the Future
Worms, worms, worms. If it isn’t whipworms it is intestinal worms – all trying to save the day for multiple sclerosis patients. Researchers have discovered…
MS symptoms: Researchers Close to a Cure for Multiple Sclerosis?
Imagine this… Multiple sclerosis patient donates their own skin cells, these cells are induced into becoming oligodendrocytes or myelin-forming cells and are reintroduced into the…
MS symptoms: HIV Medication Could Stop MS Progression?
Could having HIV actually decrease a patient’s risk of developing multiple sclerosis by 75-85%? Barts and The London Neuroimmunology Group’s blog, Multiple Sclerosis Research, posts…